These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 26295258)

  • 1. Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.
    Silva J; Monge-Fuentes V; Gomes F; Lopes K; dos Anjos L; Campos G; Arenas C; Biolchi A; Gonçalves J; Galante P; Campos L; Mortari M
    Toxins (Basel); 2015 Aug; 7(8):3179-209. PubMed ID: 26295258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders.
    Niazi ZR; Khan N; Khan S; Alam M; Kamal MA
    Protein Pept Lett; 2018; 25(7):633-642. PubMed ID: 29921193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.
    Moreno M; Giralt E
    Toxins (Basel); 2015 Apr; 7(4):1126-50. PubMed ID: 25835385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Introduction to the Toxins Special Issue on "Bee and Wasp Venoms: Biological Characteristics and Therapeutic Application".
    Pak SC
    Toxins (Basel); 2016 Oct; 8(11):. PubMed ID: 27801836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of Venom Proteins and Peptides with Possible Therapeutic Applications from Bees and WASPS.
    Ye X; Guan S; Liu J; Ng CC; Chan GH; Sze SC; Zhang KY; Naude R; Rolka K; Wong JH; Ng TB
    Protein Pept Lett; 2016; 23(8):748-55. PubMed ID: 27323949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities.
    Aufschnaiter A; Kohler V; Khalifa S; Abd El-Wahed A; Du M; El-Seedi H; Büttner S
    Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31973181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease.
    Kim ME; Lee JY; Lee KM; Park HR; Lee E; Lee Y; Lee JS; Lee J
    Arch Pharm Res; 2016 Aug; 39(8):1160-70. PubMed ID: 27469335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bee venom therapy: Potential mechanisms and therapeutic applications.
    Zhang S; Liu Y; Ye Y; Wang XR; Lin LT; Xiao LY; Zhou P; Shi GX; Liu CZ
    Toxicon; 2018 Jun; 148():64-73. PubMed ID: 29654868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When can desensitization with bee and wasp venom be stopped?].
    Oei HD; Stroes ES; Beukema WP; van der Zwan JC
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):719-20. PubMed ID: 2038399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A; Bonneau JC; Drouet M; Le Sellin J
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic biomolecules of hymenopteran venom against SARS-CoV-2 from Egyptian patients.
    Abd El Maksoud EA; Rady MH; Mahmoud AGT; Hamza D; Seadawy MG; Essa EE
    Sci Rep; 2024 Jul; 14(1):15363. PubMed ID: 38965389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent sensitization to bee and wasp venoms].
    Höveler H; Pullmann H; Gottmann-Lückerath I
    Z Hautkr; 1983 Feb; 58(3):161-6, 169-70. PubMed ID: 6845790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of bee venom on fibrosis causing inflammatory diseases.
    Lee WR; Pak SC; Park KK
    Toxins (Basel); 2015 Nov; 7(11):4758-72. PubMed ID: 26580653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy.
    Eberlein-König B; Schmidt-Leidescher C; Rakoski J; Behrendt H; Ring J
    J Investig Allergol Clin Immunol; 2006; 16(1):5-10. PubMed ID: 16599242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the venom of the bee wolf wasp, Philanthus triangulum F., on contraction and presynaptic vesicles in locust muscle.
    Njio KD; Piek T
    Toxicon; 1979; 17(6):631-8. PubMed ID: 524388
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
    Müller UR; Golden DB; Demarco PJ; Lockey RF
    Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J; Lonsdorf G; Schury W; Burg G
    MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Doo AR; Kim ST; Kim SN; Moon W; Yin CS; Chae Y; Park HK; Lee H; Park HJ
    Neurol Res; 2010 Feb; 32 Suppl 1():88-91. PubMed ID: 20034453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wasp Venom Toxins as a Potential Therapeutic Agent.
    Dongol Y; Dhananjaya BL; Shrestha RK; Aryal G
    Protein Pept Lett; 2016; 23(8):688-98. PubMed ID: 27165407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.